Company profile
U.S. Physical Therapy, Inc.
NYSE: USPH · Healthcare · Medical - Care Facilities
#176 of 1,418 Healthcare companies by revenue62nd-percentile growth
EA Score
80B+FH 80DQ 80GM 73SS 90
v0.1 · 65/100 weight · provisional
↑ growth stability, listing tenure · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$729.2M
Rev growth YoY (TTM)
+9.1%
Net income (FY)
$39.6M
Employees
6,374
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$781.0M$781.0M2025
Net income$39.6M$39.6M2025
Operating income$86.7M$86.7M2025
Total assets$1.2B$1.2B2025
Liabilities$433.8M$433.8M2025
Equity$476.4M$476.4M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Net Patient Revenues83%
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues17%
By geography
Not disclosed.
The read
What is U.S. Physical Therapy, Inc.’s revenue?
U.S. Physical Therapy, Inc. booked $781.0M in FY2025 revenue, growing 16% year over year — faster than most Healthcare companies we track, at a 5.1% net margin.
Peers · Healthcare
Tilray Brands, Inc.52DCaris Life Sciences, Inc.61CGoodRx Holdings, Inc.68BCollegium Pharmaceutical, Inc.73BAlphatec Holdings, Inc.77B+Corcept Therapeutics Incorporated84B+Neighbors
Harris →Key facts
CEOChristopher J. Reading
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersHouston, TX
ExchangeNYSE: USPH
Employees6,374
IPO date1992-05-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.